Literature DB >> 21282866

A novel knowledge-driven systems biology approach for phenotype prediction upon genetic intervention.

Rui Chang1, Robert Shoemaker, Wei Wang.   

Abstract

Deciphering the biological networks underlying complex phenotypic traits, e.g., human disease is undoubtedly crucial to understand the underlying molecular mechanisms and to develop effective therapeutics. Due to the network complexity and the relatively small number of available experiments, data-driven modeling is a great challenge for deducing the functions of genes/proteins in the network and in phenotype formation. We propose a novel knowledge-driven systems biology method that utilizes qualitative knowledge to construct a Dynamic Bayesian network (DBN) to represent the biological network underlying a specific phenotype. Edges in this network depict physical interactions between genes and/or proteins. A qualitative knowledge model first translates typical molecular interactions into constraints when resolving the DBN structure and parameters. Therefore, the uncertainty of the network is restricted to a subset of models which are consistent with the qualitative knowledge. All models satisfying the constraints are considered as candidates for the underlying network. These consistent models are used to perform quantitative inference. By in silico inference, we can predict phenotypic traits upon genetic interventions and perturbing in the network. We applied our method to analyze the puzzling mechanism of breast cancer cell proliferation network and we accurately predicted cancer cell growth rate upon manipulating (anti)cancerous marker genes/proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282866      PMCID: PMC3211072          DOI: 10.1109/TCBB.2011.18

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  39 in total

1.  Random Boolean network models and the yeast transcriptional network.

Authors:  Stuart Kauffman; Carsten Peterson; Björn Samuelsson; Carl Troein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 2.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

3.  A Bayesian approach to reconstructing genetic regulatory networks with hidden factors.

Authors:  Matthew J Beal; Francesco Falciani; Zoubin Ghahramani; Claudia Rangel; David L Wild
Journal:  Bioinformatics       Date:  2004-09-07       Impact factor: 6.937

4.  Gene regulatory network reconstruction by Bayesian integration of prior knowledge and/or different experimental conditions.

Authors:  Adriano V Werhli; Dirk Husmeier
Journal:  J Bioinform Comput Biol       Date:  2008-06       Impact factor: 1.122

5.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.

Authors:  Jérôme Eeckhoute; Jason S Carroll; Timothy R Geistlinger; Maria I Torres-Arzayus; Myles Brown
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

7.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Authors:  I Reynisdóttir; K Polyak; A Iavarone; J Massagué
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

8.  Redundant cyclin overexpression and gene amplification in breast cancer cells.

Authors:  K Keyomarsi; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

9.  Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.

Authors:  C N Robson; V Gnanapragasam; R L Byrne; A T Collins; D E Neal
Journal:  J Endocrinol       Date:  1999-02       Impact factor: 4.286

10.  Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells.

Authors:  K J Sweeney; A Swarbrick; R L Sutherland; E A Musgrove
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

View more
  5 in total

Review 1.  Systems biology data analysis methodology in pharmacogenomics.

Authors:  Andrei S Rodin; Grigoriy Gogoshin; Eric Boerwinkle
Journal:  Pharmacogenomics       Date:  2011-09       Impact factor: 2.533

2.  Systematic search for recipes to generate induced pluripotent stem cells.

Authors:  Rui Chang; Robert Shoemaker; Wei Wang
Journal:  PLoS Comput Biol       Date:  2011-12-22       Impact factor: 4.475

Review 3.  Changing Trends in Computational Drug Repositioning.

Authors:  Jaswanth K Yella; Suryanarayana Yaddanapudi; Yunguan Wang; Anil G Jegga
Journal:  Pharmaceuticals (Basel)       Date:  2018-06-05

4.  Predictive network modeling in human induced pluripotent stem cells identifies key driver genes for insulin responsiveness.

Authors:  Ivan Carcamo-Orive; Marc Y R Henrion; Kuixi Zhu; Noam D Beckmann; Paige Cundiff; Sara Moein; Zenan Zhang; Melissa Alamprese; Sunita L D'Souza; Martin Wabitsch; Eric E Schadt; Thomas Quertermous; Joshua W Knowles; Rui Chang
Journal:  PLoS Comput Biol       Date:  2020-12-23       Impact factor: 4.475

5.  From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine.

Authors:  Erfan Younesi; Martin Hofmann-Apitius
Journal:  EPMA J       Date:  2013-11-06       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.